DEPRESSION SCREENING IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

  • A. I. ENACHE “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • T. MIHAESCU Clinical Hospital of Pneumology Iasi

Abstract

DEPRESSION SCREENING IN PATIENTS WTH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (Abstract): The aim of this study was screening for depression in patients with COPD. Material and methods: Depression was diagnosed with the Hamilton 17 items questionnaire. All patients were assessed by history taking, physical exam, blood pressure (BP), spirometry, heart rate (HR), mMRC scale (Modified research Council). Results: The study included 312 patients with COPD admitted in the Clinical Hospital of Pneumology Iasi during 1-st March 2015 to 1st March 2017. The subjects were mainly males, with a median age of 65.4±4.1 years, a history of current or former cigarette smoking of 30 packs-year. Items of Hamilton Questionnaire: Item 5 (72%) - Mark 1-2-3 times night awaking, without problems feeling asleep again.  Item 7 (50%) - Marks 2,3,4, Decreased performance, considerable loss of interest, frequent abandon of fulfilling tasks, even for those essential, lack of decisions, hesitations (directly or indirectly described). mMRC Dyspnea Grades/patient: Grade 3. Conclusions: 70% of COPD patients have low to moderate depression. 100% of subjects are former or current smokers, which is a known risk factor for COPD. 89% of patients were diagnosed with moderate to severe airway obstructive dysfunction.

Author Biography

A. I. ENACHE, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine

References

1. Duţu St, Păun G. Prevalenţa simptomelor respiratorii, a astmului bronşic şi bronşitei cronice (simple şi obstructive) într-un eşantion reprezentativ de populaţie adultă rurală. Pneumoftiziologia 1998; 47(3): 151-160.
2. ***World Health Organization World and Europe Mortality Databases (November 2011 update) 39 countries that provided data on mortality to the WHO.
3. Schroedl C, Yountet S, et al. Outpatient Palliative Care for Chronic Obstructive Pulmonary Disease: A Case Series. J Palliat Med 2014; 17(11): 1256-1261.
4. Antohe I, Antoniu SA, Gavrilovici C. Triple fixed inhaled therapy in frequent chronic obstructive pulmonary disease exacerbators: potential advantages for various degrees of airways obstruction. Expert Opinion on Pharmacotherapy 2018; 19(3): 297-299.
5. Antoniu SA, Antohe I. Evaluation of inhaled tiotropium in asthma, uncontrolled with standard com-bination therapy. Expert Opinion on Pharmacother 2013; 14(7): 967-969.
6. Antohe I, Croitoru R, Antoniu S. Tralokinumamb for uncontrolled asthma. Expert Opin Biol Ther 2013; 13(2): 323-326.
7. Jee Hoon Sohn, Seung HeeAhn, et al. Prevalence, Work-Loss Days and Quality of Life of Community Dwelling Subjects with Depressive Symptoms. J Korean Med Sci 2013; 28(2): 280-286.
8. Stage KB, Middelboe T, Stage TB, et al. Depression in COPD-management and quality of life con-siderations. Int J Chron Obstruct Pulmon Dis 2006; 1(3): 315-320.
9. Willgoss TG, Yohannes AM. Anxiety Disorders in Patients with COPD: A Systematic Review. Res-piratory Care 2013; 58(5): 858-866.
Published
2018-10-03
Section
INTERNAL MEDICINE - PEDIATRICS